Quiz answers · EverLife Capital Brief, November 6, 2026
Tap your pick in the email and you land on just your answer, in its own box. Read that box, then head back to the email for the next question.
Paid links: EverLife Capital earns a referral fee if you subscribe to a recommended newsletter (one click). I only include things I believe can help you.
· · ·
Question 1 Answer A
✅ Correct!
You picked low fitness. Nice work.
What worked: In 122,007 patients who took a treadmill test at the Cleveland Clinic and were followed for about 8 years, the fittest had about 80% lower risk of dying than the least fit. Low fitness carried more risk than smoking, and the benefit held at every age, including people over 70.
Use it this week:
Find your starting point: walk as far as you comfortably can in 12 minutes on a flat route and note the distance. Repeat it in 4 weeks.
Build the base: aim for at least 150 minutes a week of brisk walking, about 30 minutes, 5 days a week.
Add one harder day: walk fast enough that talking is hard for 1 minute, then easy for 2, and repeat 4 times.
If you have heart disease or chest symptoms, check with your doctor before adding hard efforts.
Source: Mandsager et al., JAMA Network Open, 2018; US Physical Activity Guidelines for Americans
Make it stick: Quiet Habits is a free newsletter from a physician on health, aging and the small habits that shape how we live. Try Quiet Habits free →
That’s your answer to Question 1. Head back to your email for Question 2, or jump to your score →
· · ·
Question 1 Answer B
❌ Not quite.
You picked high cholesterol. Cholesterol matters, but in this study low fitness was linked to more risk than smoking, diabetes or heart disease. The answer is A) Low fitness.
What worked: In 122,007 patients who took a treadmill test at the Cleveland Clinic and were followed for about 8 years, the fittest had about 80% lower risk of dying than the least fit. Low fitness carried more risk than smoking, and the benefit held at every age, including people over 70.
Use it this week:
Find your starting point: walk as far as you comfortably can in 12 minutes on a flat route and note the distance. Repeat it in 4 weeks.
Build the base: aim for at least 150 minutes a week of brisk walking, about 30 minutes, 5 days a week.
Add one harder day: walk fast enough that talking is hard for 1 minute, then easy for 2, and repeat 4 times.
If you have heart disease or chest symptoms, check with your doctor before adding hard efforts.
Source: Mandsager et al., JAMA Network Open, 2018; US Physical Activity Guidelines for Americans
Make it stick: Quiet Habits is a free newsletter from a physician on health, aging and the small habits that shape how we live. Try Quiet Habits free →
That’s your answer to Question 1. Head back to your email for Question 2, or jump to your score →
· · ·
Question 1 Answer C
❌ Not quite.
You picked poor sleep. Sleep matters, but this study measured fitness, and low fitness came out as one of the strongest risks of all. The answer is A) Low fitness.
What worked: In 122,007 patients who took a treadmill test at the Cleveland Clinic and were followed for about 8 years, the fittest had about 80% lower risk of dying than the least fit. Low fitness carried more risk than smoking, and the benefit held at every age, including people over 70.
Use it this week:
Find your starting point: walk as far as you comfortably can in 12 minutes on a flat route and note the distance. Repeat it in 4 weeks.
Build the base: aim for at least 150 minutes a week of brisk walking, about 30 minutes, 5 days a week.
Add one harder day: walk fast enough that talking is hard for 1 minute, then easy for 2, and repeat 4 times.
If you have heart disease or chest symptoms, check with your doctor before adding hard efforts.
Source: Mandsager et al., JAMA Network Open, 2018; US Physical Activity Guidelines for Americans
Make it stick: Quiet Habits is a free newsletter from a physician on health, aging and the small habits that shape how we live. Try Quiet Habits free →
That’s your answer to Question 1. Head back to your email for Question 2, or jump to your score →
· · ·
Question 2 Answer A
✅ Correct!
You picked Lp(a). Nice work.
What worked: About 1 in 5 people have high Lp(a), a particle in the blood that raises heart attack and stroke risk. It's mostly inherited, so diet and exercise barely change it, and a standard cholesterol test doesn't measure it. European and US lipid guidelines now recommend testing it at least once in adulthood.
Why it matters: a high number doesn't mean something will happen. It means your other risks deserve more attention, and the proven response today is bringing LDL cholesterol and blood pressure down further.
Use it this week:
Ask for Lp(a) to be added to your next blood draw. It's a one-time test for most people.
If it's high, ask your doctor whether your LDL and blood pressure targets should be lower.
Tell your family. It runs in families, so siblings and children may have it too.
What's coming: No drug that lowers Lp(a) is approved yet. The first large outcome trial, Novartis's, failed in September 2026. Amgen's and Eli Lilly's trials are expected to report around 2028 and 2029.
Sources: National Lipid Association; Family Heart Foundation; Novartis via TCTMD, Sept 2026
Want the full picture on the Lp(a) race? EverLife Capital Members get the company-by-company breakdown: who is closest, what to watch, and the warning signs.
That’s your answer to Question 2. Head back to your email for Question 3, or jump to your score →
· · ·
Question 2 Answer B
❌ Not quite.
You picked LDL cholesterol. LDL is on every standard cholesterol test. The inherited one most tests skip is Lp(a). The answer is A) Lp(a).
What worked: About 1 in 5 people have high Lp(a), a particle in the blood that raises heart attack and stroke risk. It's mostly inherited, so diet and exercise barely change it, and a standard cholesterol test doesn't measure it. European and US lipid guidelines now recommend testing it at least once in adulthood.
Why it matters: a high number doesn't mean something will happen. It means your other risks deserve more attention, and the proven response today is bringing LDL cholesterol and blood pressure down further.
Use it this week:
Ask for Lp(a) to be added to your next blood draw. It's a one-time test for most people.
If it's high, ask your doctor whether your LDL and blood pressure targets should be lower.
Tell your family. It runs in families, so siblings and children may have it too.
What's coming: No drug that lowers Lp(a) is approved yet. The first large outcome trial, Novartis's, failed in September 2026. Amgen's and Eli Lilly's trials are expected to report around 2028 and 2029.
Sources: National Lipid Association; Family Heart Foundation; Novartis via TCTMD, Sept 2026
Want the full picture on the Lp(a) race? EverLife Capital Members get the company-by-company breakdown: who is closest, what to watch, and the warning signs.
That’s your answer to Question 2. Head back to your email for Question 3, or jump to your score →
· · ·
Question 2 Answer C
❌ Not quite.
You picked blood sugar. Blood sugar is checked at most checkups. The inherited heart risk most tests skip is Lp(a). The answer is A) Lp(a).
What worked: About 1 in 5 people have high Lp(a), a particle in the blood that raises heart attack and stroke risk. It's mostly inherited, so diet and exercise barely change it, and a standard cholesterol test doesn't measure it. European and US lipid guidelines now recommend testing it at least once in adulthood.
Why it matters: a high number doesn't mean something will happen. It means your other risks deserve more attention, and the proven response today is bringing LDL cholesterol and blood pressure down further.
Use it this week:
Ask for Lp(a) to be added to your next blood draw. It's a one-time test for most people.
If it's high, ask your doctor whether your LDL and blood pressure targets should be lower.
Tell your family. It runs in families, so siblings and children may have it too.
What's coming: No drug that lowers Lp(a) is approved yet. The first large outcome trial, Novartis's, failed in September 2026. Amgen's and Eli Lilly's trials are expected to report around 2028 and 2029.
Sources: National Lipid Association; Family Heart Foundation; Novartis via TCTMD, Sept 2026
Want the full picture on the Lp(a) race? EverLife Capital Members get the company-by-company breakdown: who is closest, what to watch, and the warning signs.
That’s your answer to Question 2. Head back to your email for Question 3, or jump to your score →
· · ·
Question 3 Answer A
❌ Not quite.
You picked flu. In the Wales data, people who got the flu vaccine showed no difference in dementia. The link was with the shingles vaccine. The answer is B) Shingles.
What worked: Two large studies point the same way.
Wales: people born just after the cutoff date to qualify for an older shingles vaccine had about 20% fewer new dementia diagnoses over 7 years than people born just before it. Since the only difference was birth date, it's close to a real experiment.
United States: in health records, people who got today's vaccine, Shingrix, went about 17% longer without a dementia diagnosis than people who got the older one.
The honest caveat: these studies show a link, not proof, and no one yet knows exactly why. The vaccine's main job, preventing painful shingles, is proven.
Use it this week:
Ask your doctor or pharmacist about Shingrix. It's recommended for adults 50 and older, as 2 shots given 2 to 6 months apart.
Many pharmacies give it without an appointment. Check whether your insurance covers it.
If you had the older vaccine years ago, ask whether you should also get Shingrix.
Who makes it: GSK (GSK), public. $51.15 per US share at the Nov 4 close, market value about $102 billion, cash about £3.1 billion [about $4 billion] (June 30, 2026).
Sources: Eyting et al., Nature, 2025; Taquet et al., Nature Medicine, 2024; CDC
Keep your mind sharp: A Little Wiser is a free 3-minute newsletter with three quick lessons, three mornings a week. Try A Little Wiser free →
That’s your answer to Question 3. Head back to your email for Question 4, or jump to your score →
· · ·
Question 3 Answer B
✅ Correct!
You picked shingles. Nice work.
What worked: Two large studies point the same way.
Wales: people born just after the cutoff date to qualify for an older shingles vaccine had about 20% fewer new dementia diagnoses over 7 years than people born just before it. Since the only difference was birth date, it's close to a real experiment.
United States: in health records, people who got today's vaccine, Shingrix, went about 17% longer without a dementia diagnosis than people who got the older one.
The honest caveat: these studies show a link, not proof, and no one yet knows exactly why. The vaccine's main job, preventing painful shingles, is proven.
Use it this week:
Ask your doctor or pharmacist about Shingrix. It's recommended for adults 50 and older, as 2 shots given 2 to 6 months apart.
Many pharmacies give it without an appointment. Check whether your insurance covers it.
If you had the older vaccine years ago, ask whether you should also get Shingrix.
Who makes it: GSK (GSK), public. $51.15 per US share at the Nov 4 close, market value about $102 billion, cash about £3.1 billion [about $4 billion] (June 30, 2026).
Sources: Eyting et al., Nature, 2025; Taquet et al., Nature Medicine, 2024; CDC
Keep your mind sharp: A Little Wiser is a free 3-minute newsletter with three quick lessons, three mornings a week. Try A Little Wiser free →
That’s your answer to Question 3. Head back to your email for Question 4, or jump to your score →
· · ·
Question 3 Answer C
❌ Not quite.
You picked pneumonia. These two studies looked at shingles vaccines, and that's where the link showed up. The answer is B) Shingles.
What worked: Two large studies point the same way.
Wales: people born just after the cutoff date to qualify for an older shingles vaccine had about 20% fewer new dementia diagnoses over 7 years than people born just before it. Since the only difference was birth date, it's close to a real experiment.
United States: in health records, people who got today's vaccine, Shingrix, went about 17% longer without a dementia diagnosis than people who got the older one.
The honest caveat: these studies show a link, not proof, and no one yet knows exactly why. The vaccine's main job, preventing painful shingles, is proven.
Use it this week:
Ask your doctor or pharmacist about Shingrix. It's recommended for adults 50 and older, as 2 shots given 2 to 6 months apart.
Many pharmacies give it without an appointment. Check whether your insurance covers it.
If you had the older vaccine years ago, ask whether you should also get Shingrix.
Who makes it: GSK (GSK), public. $51.15 per US share at the Nov 4 close, market value about $102 billion, cash about £3.1 billion [about $4 billion] (June 30, 2026).
Sources: Eyting et al., Nature, 2025; Taquet et al., Nature Medicine, 2024; CDC
Keep your mind sharp: A Little Wiser is a free 3-minute newsletter with three quick lessons, three mornings a week. Try A Little Wiser free →
That’s your answer to Question 3. Head back to your email for Question 4, or jump to your score →
· · ·
Question 4 Answer A
❌ Not quite.
You picked no change. It did move. Across two trials, people who did the plan for 3 to 4 monthly cycles lowered their estimated biological age by about 2.5 years on average. The answer is B) About 2.5 years.
What worked: In two clinical trials of adults 18 to 70, people ate a low-calorie, mostly plant-based meal plan for 5 days a month, then ate normally, for 3 to 4 months. Compared with people on normal or Mediterranean-style diets, they had less insulin resistance, lower long-term blood sugar (HbA1c), less belly and liver fat, and an estimated biological age about 2.5 years younger.
The honest caveats: "biological age" here is an estimate from blood and health markers, not a measure of how long anyone will live. The diet was created by Valter Longo, who led the study and founded the company that sells it.
The company: L-Nutra, which sells the meal kit as ProLon. It is private, so there are no public shares.
Use it wisely:
Talk to your doctor first, especially if you take diabetes or blood pressure medicine, are underweight, pregnant or breastfeeding, or have a history of eating disorders.
If you try it, treat it as a monthly reset alongside the basics above, not a replacement for them.
Sources: Brandhorst et al., Nature Communications, 2024; USC Leonard Davis School of Gerontology
For everyday healthy eating: Healthy Living Daily is a free newsletter with simple tips for living a healthier life every day. Try Healthy Living Daily free →
That’s your answer to Question 4. Head back to your email, or jump to your score →
· · ·
Question 4 Answer B
✅ Correct!
You picked about 2.5 years. Nice work.
What worked: In two clinical trials of adults 18 to 70, people ate a low-calorie, mostly plant-based meal plan for 5 days a month, then ate normally, for 3 to 4 months. Compared with people on normal or Mediterranean-style diets, they had less insulin resistance, lower long-term blood sugar (HbA1c), less belly and liver fat, and an estimated biological age about 2.5 years younger.
The honest caveats: "biological age" here is an estimate from blood and health markers, not a measure of how long anyone will live. The diet was created by Valter Longo, who led the study and founded the company that sells it.
The company: L-Nutra, which sells the meal kit as ProLon. It is private, so there are no public shares.
Use it wisely:
Talk to your doctor first, especially if you take diabetes or blood pressure medicine, are underweight, pregnant or breastfeeding, or have a history of eating disorders.
If you try it, treat it as a monthly reset alongside the basics above, not a replacement for them.
Sources: Brandhorst et al., Nature Communications, 2024; USC Leonard Davis School of Gerontology
For everyday healthy eating: Healthy Living Daily is a free newsletter with simple tips for living a healthier life every day. Try Healthy Living Daily free →
That’s your answer to Question 4. Head back to your email, or jump to your score →
· · ·
Question 4 Answer C
❌ Not quite.
You picked about 10 years. That would be remarkable, but the measured average was about 2.5 years. The answer is B) About 2.5 years.
What worked: In two clinical trials of adults 18 to 70, people ate a low-calorie, mostly plant-based meal plan for 5 days a month, then ate normally, for 3 to 4 months. Compared with people on normal or Mediterranean-style diets, they had less insulin resistance, lower long-term blood sugar (HbA1c), less belly and liver fat, and an estimated biological age about 2.5 years younger.
The honest caveats: "biological age" here is an estimate from blood and health markers, not a measure of how long anyone will live. The diet was created by Valter Longo, who led the study and founded the company that sells it.
The company: L-Nutra, which sells the meal kit as ProLon. It is private, so there are no public shares.
Use it wisely:
Talk to your doctor first, especially if you take diabetes or blood pressure medicine, are underweight, pregnant or breastfeeding, or have a history of eating disorders.
If you try it, treat it as a monthly reset alongside the basics above, not a replacement for them.
Sources: Brandhorst et al., Nature Communications, 2024; USC Leonard Davis School of Gerontology
For everyday healthy eating: Healthy Living Daily is a free newsletter with simple tips for living a healthier life every day. Try Healthy Living Daily free →
That’s your answer to Question 4. Head back to your email, or jump to your score →
· · ·
Your Score
0 to 1 right: start with fitness. Do the 12-minute walk test this week.
2 to 3 right: add the Lp(a) test to your next blood draw.
4 of 4: you're ahead of most people. Book the Lp(a) test, ask about Shingrix, then forward the quiz to someone who'd score 0.
EverLife Capital Members
Look Beyond The Breakthrough Headlines
Members get plain-English analysis of each company we cover: who the results were shown in, and the warning signs to check before putting money in. You can also ask us to analyze the companies you care about. Free for 14 days.
Biotechnology investments can lose substantial value, including your entire investment. Clinical success or regulatory approval does not guarantee commercial success or investment returns.
Reply to any EverLife Capital email and tell me what the next quiz should cover. I read every reply.
EverLife Capital publishes general educational research, not personalized investment or medical advice, and nothing here is a recommendation to buy or sell any security. EverLife Capital earns referral fees when readers subscribe to Quiet Habits, Healthy Living Daily or A Little Wiser through this page; no company covered here paid for coverage, directly or indirectly. Studies showing a link do not prove cause and effect. Treatment, testing, vaccine and diet decisions belong with a qualified clinician. Prices are dated where shown and may have changed. EverLife Capital is published by Consult US, LLC. Neither Eric Pemper nor Consult US, LLC holds positions in companies mentioned. Some research and summaries are prepared with AI assistance and reviewed before publication.
